APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyprogesterone Caproate Injection

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Selected research

Market Analysis & Forecast

Global Hydroxyprogesterone Caproate Injection Market Analysis and Forecast 2026-2032

31 December 2025199 pages

Choose your research edition.

Industry ResearchHydroxyprogesterone Caproate Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyprogesterone Caproate Injection Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Hydroxyprogesterone Caproate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyprogesterone Caproate Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyprogesterone Caproate Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.

This report presents an overview of global market for Hydroxyprogesterone Caproate Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Hydroxyprogesterone Caproate Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Hydroxyprogesterone Caproate Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hydroxyprogesterone Caproate Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hydroxyprogesterone Caproate Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hydroxyprogesterone Caproate Injection sales, projected growth trends, production technology, application and end-user industry.

Hydroxyprogesterone Caproate Injection Segment by Company

AMAG Pharmaceuticals

Mcguff Pharmaceuticals Inc

Aspen Oss B.V

American Regent, Inc.

Mylan Institutional

Hydroxyprogesterone Caproate Injection Segment by Type

1 mL Injection(Including 1.1 mL)

5 mL Injection

Hydroxyprogesterone Caproate Injection Segment by Application

Hospitals Injection

Clinics Injection

Hydroxyprogesterone Caproate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyprogesterone Caproate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyprogesterone Caproate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyprogesterone Caproate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hydroxyprogesterone Caproate Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hydroxyprogesterone Caproate Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1 mL Injection(Including 1.1 mL) Major Manufacturers Table 3. 5 mL Injection Major Manufacturers Table 4. Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Injection Major Manufacturers Table 6. Clinics Injection Major Manufacturers Table 7. Hydroxyprogesterone Caproate Injection Industry Trends Table 8. Hydroxyprogesterone Caproate Injection Industry Drivers Table 9. Hydroxyprogesterone Caproate Injection Industry Opportunities and Challenges Table 10. Hydroxyprogesterone Caproate Injection Industry Restraints Table 11. Global Hydroxyprogesterone Caproate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Hydroxyprogesterone Caproate Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2021-2026) Table 15. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2027-2032) Table 16. Global Hydroxyprogesterone Caproate Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2026) & (K Units) Table 18. Global Hydroxyprogesterone Caproate Injection Sales by Region (2027-2032) & (K Units) Table 19. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2021-2026) Table 20. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2027-2032) Table 21. Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Hydroxyprogesterone Caproate Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Hydroxyprogesterone Caproate Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Hydroxyprogesterone Caproate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Hydroxyprogesterone Caproate Injection Manufacturers, Product Type & Application Table 29. Global Hydroxyprogesterone Caproate Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Hydroxyprogesterone Caproate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Hydroxyprogesterone Caproate Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Hydroxyprogesterone Caproate Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2021-2026) Table 36. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2027-2032) Table 37. Global Hydroxyprogesterone Caproate Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 39. Global Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (K Units) Table 40. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2021-2026) Table 41. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2027-2032) Table 42. Global Hydroxyprogesterone Caproate Injection Price by Type (2021-2026) & (US$/Unit) Table 43. Global Hydroxyprogesterone Caproate Injection Price by Type (2027-2032) & (US$/Unit) Table 44. Global Hydroxyprogesterone Caproate Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2021-2026) Table 48. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2027-2032) Table 49. Global Hydroxyprogesterone Caproate Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 51. Global Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (K Units) Table 52. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2021-2026) Table 53. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2027-2032) Table 54. Global Hydroxyprogesterone Caproate Injection Price by Application (2021-2026) & (US$/Unit) Table 55. Global Hydroxyprogesterone Caproate Injection Price by Application (2027-2032) & (US$/Unit) Table 56. AMAG Pharmaceuticals Company Information Table 57. AMAG Pharmaceuticals Business Overview Table 58. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio Table 60. AMAG Pharmaceuticals Recent Development Table 61. Mcguff Pharmaceuticals Inc Company Information Table 62. Mcguff Pharmaceuticals Inc Business Overview Table 63. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio Table 65. Mcguff Pharmaceuticals Inc Recent Development Table 66. Aspen Oss B.V Company Information Table 67. Aspen Oss B.V Business Overview Table 68. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio Table 70. Aspen Oss B.V Recent Development Table 71. American Regent, Inc. Company Information Table 72. American Regent, Inc. Business Overview Table 73. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio Table 75. American Regent, Inc. Recent Development Table 76. Mylan Institutional Company Information Table 77. Mylan Institutional Business Overview Table 78. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio Table 80. Mylan Institutional Recent Development Table 81. North America Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Hydroxyprogesterone Caproate Injection Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 84. North America Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (K Units) Table 85. North America Hydroxyprogesterone Caproate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 86. North America Hydroxyprogesterone Caproate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 87. North America Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Hydroxyprogesterone Caproate Injection Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 90. North America Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (K Units) Table 91. North America Hydroxyprogesterone Caproate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 92. North America Hydroxyprogesterone Caproate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 93. North America Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Hydroxyprogesterone Caproate Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 97. North America Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 98. North America Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 99. North America Hydroxyprogesterone Caproate Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 100. North America Hydroxyprogesterone Caproate Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 101. United States Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 102. Canada Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 103. Mexico Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 104. Europe Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Hydroxyprogesterone Caproate Injection Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 107. Europe Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (K Units) Table 108. Europe Hydroxyprogesterone Caproate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 109. Europe Hydroxyprogesterone Caproate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 110. Europe Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Hydroxyprogesterone Caproate Injection Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 113. Europe Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (K Units) Table 114. Europe Hydroxyprogesterone Caproate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 115. Europe Hydroxyprogesterone Caproate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 116. Europe Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 121. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 122. Europe Hydroxyprogesterone Caproate Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 123. Europe Hydroxyprogesterone Caproate Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 124. Germany Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 125. France Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 126. U.K. Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 127. Italy Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 128. Russia Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 129. Spain Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 132. Sweden Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 133. Poland Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 134. China Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2026) & (US$ Million) Table 135. China Hydroxyprogesterone Caproate Injection Revenue by Type (2027-2032) & (US$ Million) Table 136. China Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 137. China Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (K Units) Table 138. China Hydroxyprogesterone Caproate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Hydroxyprogesterone Caproate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2026) & (US$ Million) Table 141. China Hydroxyprogesterone Caproate Injection Revenue by Application (2027-2032) & (US$ Million) Table 142. China Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 143. China Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (K Units) Table 144. China Hydroxyprogesterone Caproate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Hydroxyprogesterone Caproate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Hydroxyprogesterone Caproate Injection Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 149. Asia Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (K Units) Table 150. Asia Hydroxyprogesterone Caproate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Hydroxyprogesterone Caproate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Hydroxyprogesterone Caproate Injection Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 155. Asia Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (K Units) Table 156. Asia Hydroxyprogesterone Caproate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Hydroxyprogesterone Caproate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Hydroxyprogesterone Caproate Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 163. Asia Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 164. Asia Hydroxyprogesterone Caproate Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Hydroxyprogesterone Caproate Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 167. South Korea Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 168. India Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 169. Australia Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Hydroxyprogesterone Caproate Injection Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Hydroxyprogesterone Caproate Injection Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Hydroxyprogesterone Caproate Injection Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Hydroxyprogesterone Caproate Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Hydroxyprogesterone Caproate Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Hydroxyprogesterone Caproate Injection Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Hydroxyprogesterone Caproate Injection Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Hydroxyprogesterone Caproate Injection Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Hydroxyprogesterone Caproate Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Hydroxyprogesterone Caproate Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Hydroxyprogesterone Caproate Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Hydroxyprogesterone Caproate Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Hydroxyprogesterone Caproate Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 193. Argentina Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 194. Chile Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 195. Colombia Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 196. Peru Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 198. Israel Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 199. UAE Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 200. Turkey Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 201. Iran Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 202. Egypt Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Hydroxyprogesterone Caproate Injection Distributors List Table 206. Hydroxyprogesterone Caproate Injection Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Hydroxyprogesterone Caproate Injection Image Figure 2. Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyprogesterone Caproate Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1 mL Injection(Including 1.1 mL) Image Figure 5. 5 mL Injection Image Figure 6. Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hydroxyprogesterone Caproate Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Injection Image Figure 9. Clinics Injection Image Figure 10. Global Hydroxyprogesterone Caproate Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Hydroxyprogesterone Caproate Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Hydroxyprogesterone Caproate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Hydroxyprogesterone Caproate Injection Sales (2021-2032) & (K Units) Figure 16. Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Hydroxyprogesterone Caproate Injection Sales YoY (2021-2032) & (K Units) Figure 19. Europe Hydroxyprogesterone Caproate Injection Sales YoY (2021-2032) & (K Units) Figure 20. China Hydroxyprogesterone Caproate Injection Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Hydroxyprogesterone Caproate Injection Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Hydroxyprogesterone Caproate Injection Sales YoY (2021-2032) & (K Units) Figure 23. Global Hydroxyprogesterone Caproate Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Hydroxyprogesterone Caproate Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Hydroxyprogesterone Caproate Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2021-2032) Figure 32. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Hydroxyprogesterone Caproate Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2021-2032) Figure 38. North America Hydroxyprogesterone Caproate Injection Revenue Share by Type (2021-2032) Figure 39. North America Hydroxyprogesterone Caproate Injection Sales Share by Type (2021-2032) Figure 40. North America Hydroxyprogesterone Caproate Injection Revenue Share by Application (2021-2032) Figure 41. North America Hydroxyprogesterone Caproate Injection Sales Share by Application (2021-2032) Figure 42. North America Hydroxyprogesterone Caproate Injection Revenue Share by Country (2021-2032) Figure 43. North America Hydroxyprogesterone Caproate Injection Sales Share by Country (2021-2032) Figure 44. Europe Hydroxyprogesterone Caproate Injection Revenue Share by Type (2021-2032) Figure 45. Europe Hydroxyprogesterone Caproate Injection Sales Share by Type (2021-2032) Figure 46. Europe Hydroxyprogesterone Caproate Injection Revenue Share by Application (2021-2032) Figure 47. Europe Hydroxyprogesterone Caproate Injection Sales Share by Application (2021-2032) Figure 48. Europe Hydroxyprogesterone Caproate Injection Revenue Share by Country (2021-2032) Figure 49. Europe Hydroxyprogesterone Caproate Injection Sales Share by Country (2021-2032) Figure 50. China Hydroxyprogesterone Caproate Injection Revenue Share by Type (2021-2032) Figure 51. China Hydroxyprogesterone Caproate Injection Sales Share by Type (2021-2032) Figure 52. China Hydroxyprogesterone Caproate Injection Revenue Share by Application (2021-2032) Figure 53. China Hydroxyprogesterone Caproate Injection Sales Share by Application (2021-2032) Figure 54. Asia Hydroxyprogesterone Caproate Injection Revenue Share by Type (2021-2032) Figure 55. Asia Hydroxyprogesterone Caproate Injection Sales Share by Type (2021-2032) Figure 56. Asia Hydroxyprogesterone Caproate Injection Revenue Share by Application (2021-2032) Figure 57. Asia Hydroxyprogesterone Caproate Injection Sales Share by Application (2021-2032) Figure 58. Asia Hydroxyprogesterone Caproate Injection Revenue Share by Country (2021-2032) Figure 59. Asia Hydroxyprogesterone Caproate Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Hydroxyprogesterone Caproate Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Hydroxyprogesterone Caproate Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Hydroxyprogesterone Caproate Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Hydroxyprogesterone Caproate Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Hydroxyprogesterone Caproate Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Hydroxyprogesterone Caproate Injection Sales Share by Country (2021-2032) Figure 66. Hydroxyprogesterone Caproate Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hydroxyprogesterone Caproate Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1 mL Injection(Including 1.1 mL)
  • 5 mL Injection
Applications
  • Hospitals Injection
  • Clinics Injection
Companies covered
  • AMAG Pharmaceuticals
  • Mcguff Pharmaceuticals Inc
  • Aspen Oss B.V
  • American Regent, Inc.
  • Mylan Institutional

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hydroxyprogesterone Caproate Injection Market by Type
  3. 1.2.1 Global Hydroxyprogesterone Caproate Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1 mL Injection(Including 1.1 mL)
  5. 1.2.3 5 mL Injection
  6. 1.3 Hydroxyprogesterone Caproate Injection Market by Application
  7. 1.3.1 Global Hydroxyprogesterone Caproate Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals Injection
  9. 1.3.3 Clinics Injection
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Hydroxyprogesterone Caproate Injection Market Dynamics
  1. 2.1 Hydroxyprogesterone Caproate Injection Industry Trends
  2. 2.2 Hydroxyprogesterone Caproate Injection Industry Drivers
  3. 2.3 Hydroxyprogesterone Caproate Injection Industry Opportunities and Challenges
  4. 2.4 Hydroxyprogesterone Caproate Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hydroxyprogesterone Caproate Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Region
  3. 3.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Hydroxyprogesterone Caproate Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hydroxyprogesterone Caproate Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hydroxyprogesterone Caproate Injection Sales by Region
  9. 3.4.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Hydroxyprogesterone Caproate Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturers
  2. 4.1.1 Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hydroxyprogesterone Caproate Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers
  6. 4.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hydroxyprogesterone Caproate Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hydroxyprogesterone Caproate Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hydroxyprogesterone Caproate Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hydroxyprogesterone Caproate Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hydroxyprogesterone Caproate Injection Manufacturers, Product Type & Application
  13. 4.7 Global Hydroxyprogesterone Caproate Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hydroxyprogesterone Caproate Injection Market CR5 and HHI
  16. 4.8.2 2025 Hydroxyprogesterone Caproate Injection Tier 1, Tier 2, and Tier 3
5 Hydroxyprogesterone Caproate Injection Market by Type
  1. 5.1 Global Hydroxyprogesterone Caproate Injection Revenue by Type
  2. 5.1.1 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hydroxyprogesterone Caproate Injection Sales by Type
  6. 5.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hydroxyprogesterone Caproate Injection Price by Type
6 Hydroxyprogesterone Caproate Injection Market by Application
  1. 6.1 Global Hydroxyprogesterone Caproate Injection Revenue by Application
  2. 6.1.1 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hydroxyprogesterone Caproate Injection Sales by Application
  6. 6.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hydroxyprogesterone Caproate Injection Price by Application
7 Company Profiles
  1. 7.1 AMAG Pharmaceuticals
  2. 7.1.1 AMAG Pharmaceuticals Company Information
  3. 7.1.2 AMAG Pharmaceuticals Business Overview
  4. 7.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
  6. 7.1.5 AMAG Pharmaceuticals Recent Developments
  7. 7.2 Mcguff Pharmaceuticals Inc
  8. 7.2.1 Mcguff Pharmaceuticals Inc Company Information
  9. 7.2.2 Mcguff Pharmaceuticals Inc Business Overview
  10. 7.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
  12. 7.2.5 Mcguff Pharmaceuticals Inc Recent Developments
  13. 7.3 Aspen Oss B.V
  14. 7.3.1 Aspen Oss B.V Company Information
  15. 7.3.2 Aspen Oss B.V Business Overview
  16. 7.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
  18. 7.3.5 Aspen Oss B.V Recent Developments
  19. 7.4 American Regent, Inc.
  20. 7.4.1 American Regent, Inc. Company Information
  21. 7.4.2 American Regent, Inc. Business Overview
  22. 7.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio
  24. 7.4.5 American Regent, Inc. Recent Developments
  25. 7.5 Mylan Institutional
  26. 7.5.1 Mylan Institutional Company Information
  27. 7.5.2 Mylan Institutional Business Overview
  28. 7.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
  30. 7.5.5 Mylan Institutional Recent Developments
8 North America
  1. 8.1 North America Hydroxyprogesterone Caproate Injection Market Size by Type
  2. 8.1.1 North America Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Hydroxyprogesterone Caproate Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Hydroxyprogesterone Caproate Injection Price by Type (2021-2032)
  5. 8.2 North America Hydroxyprogesterone Caproate Injection Market Size by Application
  6. 8.2.1 North America Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Hydroxyprogesterone Caproate Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Hydroxyprogesterone Caproate Injection Price by Application (2021-2032)
  9. 8.3 North America Hydroxyprogesterone Caproate Injection Market Size by Country
  10. 8.3.1 North America Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hydroxyprogesterone Caproate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hydroxyprogesterone Caproate Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hydroxyprogesterone Caproate Injection Market Size by Type
  2. 9.1.1 Europe Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hydroxyprogesterone Caproate Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Hydroxyprogesterone Caproate Injection Price by Type (2021-2032)
  5. 9.2 Europe Hydroxyprogesterone Caproate Injection Market Size by Application
  6. 9.2.1 Europe Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hydroxyprogesterone Caproate Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Hydroxyprogesterone Caproate Injection Price by Application (2021-2032)
  9. 9.3 Europe Hydroxyprogesterone Caproate Injection Market Size by Country
  10. 9.3.1 Europe Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hydroxyprogesterone Caproate Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hydroxyprogesterone Caproate Injection Market Size by Type
  2. 10.1.1 China Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Hydroxyprogesterone Caproate Injection Sales by Type (2021-2032)
  4. 10.1.3 China Hydroxyprogesterone Caproate Injection Price by Type (2021-2032)
  5. 10.2 China Hydroxyprogesterone Caproate Injection Market Size by Application
  6. 10.2.1 China Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Hydroxyprogesterone Caproate Injection Sales by Application (2021-2032)
  8. 10.2.3 China Hydroxyprogesterone Caproate Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hydroxyprogesterone Caproate Injection Market Size by Type
  2. 11.1.1 Asia Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hydroxyprogesterone Caproate Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Hydroxyprogesterone Caproate Injection Price by Type (2021-2032)
  5. 11.2 Asia Hydroxyprogesterone Caproate Injection Market Size by Application
  6. 11.2.1 Asia Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hydroxyprogesterone Caproate Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Hydroxyprogesterone Caproate Injection Price by Application (2021-2032)
  9. 11.3 Asia Hydroxyprogesterone Caproate Injection Market Size by Country
  10. 11.3.1 Asia Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hydroxyprogesterone Caproate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hydroxyprogesterone Caproate Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hydroxyprogesterone Caproate Injection Market Size by Type
  2. 12.1.1 SAMEA Hydroxyprogesterone Caproate Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hydroxyprogesterone Caproate Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hydroxyprogesterone Caproate Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Hydroxyprogesterone Caproate Injection Market Size by Application
  6. 12.2.1 SAMEA Hydroxyprogesterone Caproate Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hydroxyprogesterone Caproate Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hydroxyprogesterone Caproate Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Hydroxyprogesterone Caproate Injection Market Size by Country
  10. 12.3.1 SAMEA Hydroxyprogesterone Caproate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hydroxyprogesterone Caproate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hydroxyprogesterone Caproate Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hydroxyprogesterone Caproate Injection Value Chain Analysis
  2. 13.1.1 Hydroxyprogesterone Caproate Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hydroxyprogesterone Caproate Injection Production Mode & Process
  6. 13.2 Hydroxyprogesterone Caproate Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hydroxyprogesterone Caproate Injection Distributors
  9. 13.2.3 Hydroxyprogesterone Caproate Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst